Serum Atrial Natriuretic Peptide, NPPA Promoter Methylation, and Cardiovascular Disease: A 10-year Follow-Up Study in Chinese Adults

BACKGROUND: Atrial natriuretic peptide (ANP) has been associated with cardiovascular disease (CVD) and related risk factors, but the clinical application is limited and the underlying mechanisms are not very clear. Here, we aimed to examine whether proANP and its coding gene methylation were associa...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Linan, Li, Jing, Zhang, Min, Zhang, Qiu, Wu, Lei, Lu, Ying, He, Yan, Jiang, Jun, Zhang, Xiaolong, Hu, Jianwei, Ding, Yi, Zhang, Mingzhi, Peng, Hao
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ubiquity Press 2022
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992767/
https://www.ncbi.nlm.nih.gov/pubmed/35586748
http://dx.doi.org/10.5334/gh.1116

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8992767/
https://www.ncbi.nlm.nih.gov/pubmed/35586748
http://dx.doi.org/10.5334/gh.1116

Ejemplares similares